Bridger Aerospace Group Holdings, Inc. filed a Form 8-K on October 30, 2026, disclosing that it received a deficiency letter from the Nasdaq Listing Qualifications Department on October 28, 2026, notifying the company that its common stock no longer satisfies the minimum bid price requirement for continued listing on The Nasdaq Global Market.
Key Highlights
- Deficiency letter received: Nasdaq notified Bridger Aerospace on October 28, 2026, that the company's common stock failed to maintain a minimum bid price of $1.00 per share for the 30 consecutive business day period ended October 27, 2026.
- Listing rule at issue: The company does not satisfy Nasdaq Listing Rule 5450(a)(1), the Minimum Bid Price Requirement for The Nasdaq Global Market.
- Compliance deadline: The company has until April 26, 2027 to regain compliance with the Minimum Bid Price Requirement.
- Compliance threshold: To regain compliance, the closing bid price must be at least $1.00 per share for a minimum of ten consecutive business days during the compliance period.
- No immediate effect: The deficiency letter has no immediate effect on the listing; common stock continues to trade on The Nasdaq Global Market under the symbol "BAER."
- Options under consideration: According to the filing, the company intends to monitor the closing bid price and may consider "implementing available options (including a reverse stock split, if necessary)" to resolve the deficiency.
Bridger Aerospace Discloses Nasdaq Bid Price Deficiency and April 2027 Cure Deadline
According to the Form 8-K filed with the Securities and Exchange Commission, Bridger Aerospace Group Holdings, Inc. (NASDAQ:BAER) received a deficiency letter from the Nasdaq Listing Qualifications Department on October 28, 2026. The letter stated that, based on the closing bid price of the company's common stock over the 30 consecutive business day period ended October 27, 2026, the company no longer satisfies the $1.00 per share minimum bid price required for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1). The filing noted that the letter "has no immediate effect on the listing of the Common Stock, which continues to trade on The Nasdaq Global Market under the symbol 'BAER' at this time."
The filing disclosed that, in accordance with Nasdaq Listing Rule 5810(c)(3)(A), the company has been given a compliance period extending to April 26, 2027. During this period, the closing bid price for the common stock must reach at least $1.00 per share for a minimum of ten consecutive business days to regain compliance, unless Nasdaq staff exercises discretion under Listing Rule 5810(c)(3)(H) to extend that ten-day window. If the company does not regain compliance within the compliance period, including any extensions Nasdaq may grant, the Nasdaq staff would provide written notice that the common stock would be subject to delisting. The company noted that it could appeal any such delisting determination to a Nasdaq Hearings Panel, but stated "there can be no assurance that... such appeal would be successful."
The company disclosed that it "intends to actively monitor the closing bid price" and may consider available options, including a reverse stock split if necessary, to resolve the deficiency. However, the filing added that "there can be no assurance that the Company will be able to regain compliance." The 8-K was signed by Justin D. Mogford, General Counsel and Corporate Secretary, and is categorized under Item 3.01, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard.
What Was Disclosed
Bridger Aerospace filed an 8-K disclosing a Nasdaq deficiency letter dated October 28, 2026, citing failure to maintain a $1.00 minimum bid price for 30 consecutive business days. The company has until April 26, 2027 to regain compliance or face potential delisting proceedings.




Please wait processing your request...